Esculetin is a natural
lactone that is commonly derived from
coumarins. According to previous experiments using human
cancer cells,
esculetin has potent antitumor activity; it also inhibits proliferation and induces the apoptosis of
cancer cells. In the present study, the anti-proliferative effect of
esculetin on the submandibular salivary gland tumor cell line, A253, was evaluated via in vitro and in vivo analyses. Furthermore, the anti-
cancer effects of
esculetin in A253 cells and a xenograft model of salivary gland
tumors were determined using 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium
bromide and TUNEL assay, apoptosis
protein array, quantitative polymerase chain reaction and western blot analysis.
Esculetin (50-150 µM) was demonstrated to have an anti-proliferative effect in the A253 cell line in vitro; this observed effect was dependent on the dose and
duration of treatment.
Esculetin also increased the levels of Bax, cleaved
caspase-3, cleaved-9 and cleaved
poly (ADP-ribose) polymerase apoptosis-related
proteins, and decreased the expression levels of the Bcl-2
anti-apoptotic protein. With respect to apoptosis regulation,
esculetin significantly decreased the proliferation of
tumor cells in a xenograft model (100 mg/kg/day) for 18 days. Overall,
esculetin could be a potential oral anticancer
drug against
salivary gland cancer.